A critical task towards maximizing productivity in the manufacturing of biotherapeutics such as monoclonal antibodies is selecting the appropriate separation technology or sequence of technologies that meet the purity requirements of regulatory agencies (e.g. Health Canada) and maximize product recovery to reduce the overall cost per dose. The focus of this research project is two-fold. […]

Academic research breakthroughs have transformed the biopharmaceutical industry. Already, the majority of the top 10 best-selling drugs in the world and 40-50% of new drugs are biologics. A major and profound challenge is that the cost for the development and production of biologics is extremely high. This high cost is not sustainable since it will […]